Ogasawara S - Search Results

1

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.

Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, Verslype C, Zagonel V, Fartoux L, Vogel A, Sarker D, Verset G, Chan SL, Knox J, Daniele B, Webber AL, Ebbinghaus SW, Ma J, Siegel AB, Cheng AL, Kudo M; KEYNOTE-224 investigators. Zhu AX, et al. Among authors: ogasawara s. Lancet Oncol. 2018 Jul;19(7):940-952. doi: 10.1016/S1470-2045(18)30351-6. Epub 2018 Jun 3. Lancet Oncol. 2018. PMID: 29875066 Clinical Trial.

2

Is intra-patient sorafenib dose re-escalation safe and tolerable in patients with advanced hepatocellular carcinoma?

Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Yokosuka O. Ogasawara S, et al. Int J Clin Oncol. 2014 Dec;19(6):1029-36. doi: 10.1007/s10147-014-0668-4. Epub 2014 Feb 13. Int J Clin Oncol. 2014. PMID: 24519322

3

A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.

Ooka Y, Chiba T, Ogasawara S, Arai K, Suzuki E, Tawada A, Yamashita T, Kanai F, Kaneko S, Yokosuka O. Ooka Y, et al. Among authors: ogasawara s. Invest New Drugs. 2014 Aug;32(4):723-8. doi: 10.1007/s10637-014-0077-6. Epub 2014 Mar 7. Invest New Drugs. 2014. PMID: 24599799 Clinical Trial.

4

A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma.

Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Kanai F, Yokosuka AO. Ogasawara S, et al. Invest New Drugs. 2014 Aug;32(4):762-8. doi: 10.1007/s10637-014-0097-2. Epub 2014 Apr 16. Invest New Drugs. 2014. PMID: 24737402 Clinical Trial.

5

Effect of previous interferon-based therapy on recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.

Saito T, Chiba T, Suzuki E, Shinozaki M, Goto N, Kanogawa N, Motoyama T, Ogasawara S, Ooka Y, Tawada A, Kanda T, Miyazaki M, Yokosuka O. Saito T, et al. Among authors: ogasawara s. Int J Med Sci. 2014 May 7;11(7):707-12. doi: 10.7150/ijms.8764. eCollection 2014. Int J Med Sci. 2014. PMID: 24843320 Free PMC article.

6

Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.

Tawada A, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Saito T, Ogasawara S, Suzuki E, Maruyama H, Kanai F, Yoshikawa M, Yokosuka O. Tawada A, et al. Among authors: ogasawara s. Anticancer Res. 2014 Aug;34(8):4231-7. Anticancer Res. 2014. PMID: 25075052

7

Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.

Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Kanai F, Yoshikawa M, Yokosuka O. Ogasawara S, et al. Oncology. 2014;87(6):330-41. doi: 10.1159/000365993. Epub 2014 Sep 6. Oncology. 2014. PMID: 25227534

8

Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update.

Kudo M, Matsui O, Izumi N, Kadoya M, Okusaka T, Miyayama S, Yamakado K, Tsuchiya K, Ueshima K, Hiraoka A, Ikeda M, Ogasawara S, Yamashita T, Minami T; Liver Cancer Study Group of Japan. Kudo M, et al. Among authors: ogasawara s. Oncology. 2014;87 Suppl 1:22-31. doi: 10.1159/000368142. Epub 2014 Nov 22. Oncology. 2014. PMID: 25427730 Review.

9

Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma.

Tawada A, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Ogasawara S, Suzuki E, Kanai F, Yoshikawa M, Yokosuka O. Tawada A, et al. Among authors: ogasawara s. Anticancer Res. 2015 Jan;35(1):549-54. Anticancer Res. 2015. PMID: 25550601

10

Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors.

Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Suzuki E, Tawada A, Kanai F, Yokosuka O. Ogasawara S, et al. Invest New Drugs. 2015 Jun;33(3):729-39. doi: 10.1007/s10637-015-0237-3. Epub 2015 Apr 12. Invest New Drugs. 2015. PMID: 25861764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters